• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pembrolizumab-induced Stevens-Johnson syndrome in non-melanoma patients.

作者信息

Saw Stephanie, Lee Haur Yueh, Ng Quan Sing

机构信息

Division of Medical Oncology, National Cancer Centre, Singapore.

Department of Dermatology, Singapore General Hospital, Singapore.

出版信息

Eur J Cancer. 2017 Aug;81:237-239. doi: 10.1016/j.ejca.2017.03.026. Epub 2017 Apr 21.

DOI:10.1016/j.ejca.2017.03.026
PMID:28438440
Abstract
摘要

相似文献

1
Pembrolizumab-induced Stevens-Johnson syndrome in non-melanoma patients.帕博利珠单抗在非黑色素瘤患者中诱发史蒂文斯-约翰逊综合征。
Eur J Cancer. 2017 Aug;81:237-239. doi: 10.1016/j.ejca.2017.03.026. Epub 2017 Apr 21.
2
[Toxic epidermal necrolysis due to anti-PD1 treatment with fatal outcome].[抗程序性死亡蛋白1治疗导致中毒性表皮坏死松解症并致死]
Ann Dermatol Venereol. 2017 Jan;144(1):65-66. doi: 10.1016/j.annder.2016.11.012. Epub 2016 Dec 20.
3
Stevens-Johnson Syndrome Induced by Pembrolizumab in a Lung Cancer Patient.帕博利珠单抗诱发肺癌患者发生史蒂文斯-约翰逊综合征
J Thorac Oncol. 2018 Nov;13(11):1798-1799. doi: 10.1016/j.jtho.2018.05.031. Epub 2018 Jun 6.
4
Pembrolizumab associated Stevens-Johnson syndrome with porokeratosis in a patient in the setting of primary hepatocellular carcinoma.帕博利珠单抗相关史蒂文斯-约翰逊综合征伴原发性肝细胞癌患者的角化不良。
Australas J Dermatol. 2022 Feb;63(1):e71-e74. doi: 10.1111/ajd.13704. Epub 2021 Aug 31.
5
Stevens-Johnson syndrome manifesting late in the course of pembrolizumab therapy.史蒂文斯-约翰逊综合征在帕博利珠单抗治疗过程后期出现。
J Oncol Pharm Pract. 2019 Sep;25(6):1520-1522. doi: 10.1177/1078155218791314. Epub 2018 Aug 7.
6
Successful rechallenge with pembrolizumab after case of progressive immunotherapy-related mucocutaneous eruption (PIRME), a Stevens-Johnson syndrome-like reaction.在出现一例与免疫治疗相关的进行性黏膜皮肤疹（PIRME，一种史蒂文斯-约翰逊综合征样反应）后，帕博利珠单抗再次挑战成功。
Int J Dermatol. 2023 Oct;62(10):1292-1294. doi: 10.1111/ijd.16572. Epub 2023 Jan 11.
7
Pembrolizumab-induced Stevens-Johnson Syndrome with Severe Ocular Complications.帕博利珠单抗引起的史蒂文斯-约翰逊综合征伴严重眼部并发症。
Ocul Immunol Inflamm. 2022 Aug;30(6):1533-1535. doi: 10.1080/09273948.2021.1896006. Epub 2021 Apr 7.
8
T cell mediated hypersensitivity to previously tolerated iodinated contrast media precipitated by introduction of atezolizumab.T 细胞介导的对先前耐受的碘造影剂的超敏反应，由阿替利珠单抗的引入引发。
J Immunother Cancer. 2021 May;9(5). doi: 10.1136/jitc-2021-002521.
9
Stevens-Johnson syndrome induced by sorafenib for metastatic renal cell carcinoma.索拉非尼诱发的转移性肾细胞癌患者的史蒂文斯-约翰逊综合征。
Urol Int. 2013;91(4):482-3. doi: 10.1159/000351918. Epub 2013 Aug 16.
10
Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma.帕博利珠单抗作为透明细胞肾细胞癌辅助治疗的相关问题需要澄清。
Lancet Oncol. 2022 Nov;23(11):e488. doi: 10.1016/S1470-2045(22)00602-7.

引用本文的文献

1
MASCC/ISOO Clinical Practice Statement: management of oral complications of immunotherapy.MASCC/ISOO临床实践声明：免疫治疗口腔并发症的管理
Support Care Cancer. 2025 Sep 13;33(10):851. doi: 10.1007/s00520-025-09806-x.
2
Complex regulatory network of programmed death-ligand 1 in cancer: Cancer immunomodulation from molecular mechanisms to clinical applications.癌症中程序性死亡配体1的复杂调控网络：从分子机制到临床应用的癌症免疫调节
iScience. 2025 May 9;28(6):112615. doi: 10.1016/j.isci.2025.112615. eCollection 2025 Jun 20.
3
Adverse Cutaneous Reactions to Monoclonal Antibodies: Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, Erythema Multiforme, and Fixed Drug Eruption - A Systematic Review.
单克隆抗体的皮肤不良反应：史蒂文斯-约翰逊综合征、中毒性表皮坏死松解症、多形红斑和固定性药疹——一项系统评价
Biomed Hub. 2025 Apr 21;10(1):105-115. doi: 10.1159/000545623. eCollection 2025 Jan-Dec.
4
Clinical features of nivolumab-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: retrospective analysis based on case reports.纳武利尤单抗所致史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症的临床特征：基于病例报告的回顾性分析
Front Immunol. 2025 Mar 18;16:1563100. doi: 10.3389/fimmu.2025.1563100. eCollection 2025.
5
Camrelizumab-induced immune-related toxic epidermal necrolysis in lung adenocarcinoma: a case report and literature review.卡瑞利珠单抗诱导的肺腺癌免疫相关中毒性表皮坏死松解症：一例报告及文献综述
Front Oncol. 2025 Jan 13;14:1417936. doi: 10.3389/fonc.2024.1417936. eCollection 2024.
6
Superficial mucoceles as a sequel to Stevens‑Johnson syndrome during treatment of cutaneous squamous cell carcinoma with cemiplimab: A case report and review of literature.在使用西米普利单抗治疗皮肤鳞状细胞癌期间，史蒂文斯-约翰逊综合征继发浅表黏液囊肿：一例报告并文献复习
Exp Ther Med. 2024 Nov 18;29(1):15. doi: 10.3892/etm.2024.12765. eCollection 2025 Jan.
7
Immune-related toxic epidermal necrolysis affecting trachea mucosal epithelium: a case report and literature review.免疫相关的中毒性表皮坏死松解症累及气管黏膜上皮：一例报告及文献复习
Front Pharmacol. 2024 Oct 18;15:1454015. doi: 10.3389/fphar.2024.1454015. eCollection 2024.
8
Clinical Features of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor versus Non-Immune Checkpoint Inhibitor Drugs in China: A Cross-Sectional Study and Literature Review.中国免疫检查点抑制剂与非免疫检查点抑制剂药物所致史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的临床特征：一项横断面研究及文献综述
J Inflamm Res. 2024 Oct 22;17:7591-7605. doi: 10.2147/JIR.S491791. eCollection 2024.
9
Stevens-Johnson syndrome and toxic epidermal necrolysis associated with immune checkpoint inhibitors: a systematic review.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症与免疫检查点抑制剂相关：系统评价。
Front Immunol. 2024 Jul 12;15:1414136. doi: 10.3389/fimmu.2024.1414136. eCollection 2024.
10
Pembrolizumab-induced Stevens-Johnson syndrome/Toxic Epidermal Necrolysis in a Vietnamese patient with nonsmall-cell lung cancer.一名越南非小细胞肺癌患者发生帕博利珠单抗诱导的史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症。
Asia Pac Allergy. 2024 Jun;14(2):84-89. doi: 10.5415/apallergy.0000000000000131. Epub 2023 Dec 18.